Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1Phase 1/2 1

Status

Completed 13Recruiting 10Active not recruiting 7Terminated 5Unknown 3Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gastrointestinal 17Breast 13Thoracic 7Genitourinary 7Head & Neck 4CNS 4Sarcoma 3Endocrine 2Dermatologic 2Tumor-Agnostic 1NET 1Gynecologic 1

Conditions

Urinary Bladder Neoplasms 4Prostatic Neoplasms 2Prostate Adenocarcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

pembrolizumab 65Nivolumab 58Magnetic Resonance Spectroscopy 53enzalutamide 39Abiraterone Acetate 37Radiosurgery 36Gemcitabine 35Specimen Handling 32Radiotherapy 32Ipilimumab 32Androgen Antagonists 32Prednisone 31apalutamide 28Cisplatin 28Docetaxel 27Leuprolide 26atezolizumab 25Carboplatin 25durvalumab 23cabozantinib 23darolutamide 20acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 19olaparib 18Goserelin 17Radiation 16Gonadotropin-Releasing Hormone 16Biopsy 16gallium 68 PSMA-11 15Pluvicto 15avelumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Active not recruiting × Surgical Procedures, Operative × Genitourinary × Clear all
NCT05826509 2026-05-08

SUGAR

Institut Claudius Regaud

Phase 2 Active not recruiting
240 enrolled
Genitourinary

Prostatic Neoplasms

NCT04286386 2026-04-29

Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam

M.D. Anderson Cancer Center

Active not recruiting
130 enrolled
Genitourinary

Prostate Adenocarcinoma

NCT06305767 2026-01-13

INTerpath-005

Merck Sharp & Dohme LLC

Phase 1/2 Active not recruiting
230 enrolled
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT03978624 2025-10-15

Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Active not recruiting
20 enrolled 11 charts
Genitourinary

Urinary Bladder Neoplasms

NCT03924895 2025-08-28

KEYNOTE-905

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
595 enrolled 1 FDA
Genitourinary

Urinary Bladder Neoplasms

NCT00938145 2025-04-11

3 Tesla MRI in Patients With Bladder Cancer

University of Cincinnati

Phase NA Active not recruiting
98 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00430183 2023-02-09

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
788 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡